Retatrutide represents a pioneering peptide exhibiting substantial efficacy in body management . This treatment acts as a twin agonist for both incretin and metabolic systems, resulting in better glycemic control and decreased visceral adipose tissue . Early trial results indicate considerable physique reduction and positive physiological outcomes